Previous Article | Next Article ![]()
Mol. Cell. Biol., 05 1996, 2264-2273, Vol 16, No. 5
T Inaba, T Gotoda, S Ishibashi, K Harada, JI Ohsuga, K Ohashi, Y Yazaki and N Yamada
The macrophage colony-stimulating factor receptor encoded by the c-fms gene
is expressed in vascular intimal smooth muscle cells isolated from
atherosclerotic lesions. A combination of platelet-derived growth factor-BB
and epidermal growth factor induces stable expression of c- fms in normal
vascular medial smooth muscle cells. The mechanism by which these growth
factors induce c-fms expression has now been investigated in an attempt to
gain insight into the events that underlie the phenotypic conversion of
vascular smooth muscle cells in atherosclerosis. Deletion analysis of the
c-fms promoter revealed that the region including a binding site for
transcription factor PU.1 was required for transcriptional activity in
human aortic medial smooth muscle cells. Mutation in the PU.1 binding site
markedly reduced promoter activity. Northern (RNA) blot analysis
demonstrated that growth factors induced the expression of PU.1 mRNA in
vascular medial smooth muscle cells and that PU.1 mRNA was expressed in
vascular intimal smooth muscle cells. PU.1 antisense oligonucleotides
inhibited growth factor-induced c-fms expression and foam cell formation.
These results suggest that transcription factor PU.1 plays an essential
role in the phenotypic conversion of vascular smooth muscle cells to
macrophagelike cells by mediating the induction of c-fms.
Copyright © 1996, American Society for Microbiology
Transcription factor PU.1 mediates induction of c-fms in vascular smooth muscle cells: a mechanism for phenotypic change to phagocytic cells
3rd Department of Internal Medicine, University of Tokyo, Japan.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»